BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+3.37%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$957M
AUM Growth
+$1.08M
(+0.11%)
Cap. Flow
-$8.63M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
140
New
9
Increased
34
Reduced
55
Closed
6
Top Buys
| 1 |
DexCom
DXCM
|
$12.7M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.1M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$9.58M |
| 4 |
Incyte
INCY
|
$8.07M |
| 5 |
CELG
Celgene Corp
CELG
|
$7.5M |
Top Sells
| 1 |
Amgen
AMGN
|
$20.3M |
| 2 |
Gilead Sciences
GILD
|
$15.9M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$10.9M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$8.6M |
| 5 |
AbbVie
ABBV
|
$8.05M |
Sector Composition
| 1 | Healthcare | 95.72% |
| 2 | Financials | 0.41% |
| 3 | Industrials | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Nektar Therapeutics
NKTR
$543M
| $4.46M | 0.47% |
4,980
-3,220
| -39% | -$2.88M |
|
52
Neurocrine Biosciences
NBIX
$13.5B
| $4.23M | 0.44% |
54,500
-1,500
| -3% | -$116K |
|
53
BioMarin Pharmaceuticals
BMRN
$11.3B
| $4.02M | 0.42% |
45,050
-3,750
| -8% | -$334K |
|
54
ResMed
RMD
$39.4B
| $3.98M | 0.42% |
47,000
| – | – |
|
|
AET
55
DELISTED
Aetna Inc
AET
| $3.97M | 0.41% |
22,000
-34,700
| -61% | -$6.26M |
|
|
ESRX
56
DELISTED
Express Scripts Holding Company
ESRX
| $3.7M | 0.39% |
49,500
| – | – |
|
57
Johnson & Johnson
JNJ
$429B
| $3.63M | 0.38% |
26,000
-5,500
| -17% | -$769K |
|
58
Dentsply Sirona
XRAY
$2.77B
| $3.59M | 0.37% |
54,500
| – | – |
|
59
Teleflex
TFX
$5.57B
| $3.48M | 0.36% |
14,000
+3,800
| +37% | +$945K |
|
60
Ligand Pharmaceuticals
LGND
$3.25B
| $3.48M | 0.36% |
40,716
-37,350
| -48% | -$3.19M |
|
|
BLUE
61
DELISTED
bluebird bio
BLUE
| $3.4M | 0.36% |
1,475
-463
| -24% | -$1.07M |
|
62
Molina Healthcare
MOH
$9.6B
| $3.34M | 0.35% |
43,500
| – | – |
|
|
GNMK
63
DELISTED
GenMark Diagnostics, Inc
GNMK
| $3.23M | 0.34% |
773,677
+250,000
| +48% | +$1.04M |
|
64
Henry Schein
HSIC
$8.14B
| $3.01M | 0.31% |
54,825
+6,375
| +13% | +$349K |
|
65
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$727M
| $2.99M | 0.31% |
+1,920
| New | +$2.99M |
|
|
CERN
66
DELISTED
Cerner Corp
CERN
| $2.97M | 0.31% |
44,000
-30,500
| -41% | -$2.06M |
|
67
Perrigo
PRGO
$3.21B
| $2.88M | 0.3% |
33,000
-13,468
| -29% | -$1.17M |
|
|
SGEN
68
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.86M | 0.3% |
53,500
+8,500
| +19% | +$455K |
|
69
Alkermes
ALKS
$4.95B
| $2.83M | 0.3% |
51,700
-4,400
| -8% | -$241K |
|
70
Alnylam Pharmaceuticals
ALNY
$58.6B
| $2.81M | 0.29% |
22,100
-53,493
| -71% | -$6.8M |
|
|
AGN
71
DELISTED
Allergan plc
AGN
| $2.7M | 0.28% |
16,500
-4,000
| -20% | -$654K |
|
72
United Therapeutics
UTHR
$17.7B
| $2.55M | 0.27% |
17,200
-4,400
| -20% | -$651K |
|
73
Agios Pharmaceuticals
AGIO
$2.36B
| $2.34M | 0.24% |
40,900
-4,100
| -9% | -$234K |
|
74
McKesson
MCK
$85.9B
| $2.15M | 0.22% |
13,800
-4,200
| -23% | -$655K |
|
|
PTLA
75
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.11M | 0.22% |
43,350
+11,850
| +38% | +$577K |
|